Skip to content
Unrated Medical device recall · FDA · Published April 23, 2026

Covidien Mon-a-Therm Temperature Probe Recall: Lack of FDA Clearance

Covidien recalls Mon-a-Therm temperature probes (size 9 Fr REF 90050) due to lack of FDA clearance. Affected units have specific UDI and lot numbers. Consumers should contact the manufacturer for details.

🇺🇸 FDA recall #Z-2273-2026Medical deviceCovidien ›
Take action

Contact the company

Recalling firmCovidien LLC6135 Gunbarrel Ave · Boulder, CO 80301-3214
✎ GovInfoNow plain-language explainer

What happened, in plain English

Covidien is recalling Mon-a-Therm temperature probes that lack FDA clearance. This means the devices may not be safe for medical use, potentially causing harm if used improperly. Read more at govinfonow.com/recall/49391-covidien-mon-a-therm-temperature-probe-recall-lack-of-fda.

Source Summary by GovInfoNow · govinfonow.com/recall/49391-covidien-mon-a-therm-temperature-probe-recall-lack-of-fda · Updated August 10, 2026 · FDA enforcement record: FDA #Z-2273-2026

Cite this page

“Covidien Mon-a-Therm Temperature Probe Recall: Lack of FDA Clearance.” GovInfoNow, updated August 10, 2026. https://govinfonow.com/recall/49391-covidien-mon-a-therm-temperature-probe-recall-lack-of-fda. Based on FDA recall #Z-2273-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-2273-2026%22&limit=1).

Why it’s dangerous

The probes lack FDA clearance, meaning they have not been approved for medical use by the U.S. Food and Drug Administration. This could lead to inaccurate temperature readings or other safety issues during medical procedures.

Who’s affected

Healthcare professionals using these probes for temperature monitoring are most at risk. Patients receiving care with these devices could be exposed to potential safety issues.

How to tell if you have this one

Check for the model number 'Mon-a-Therm size 9 Fr REF 90050' on the device. Look for the unique device identifier (UDI) numbers listed in the recall notice, such as 10884521828391 or 30884521828395.

  • Brand
    Covidien
  • Category
    Medical device
FDA recall event · 3 products

All 3 products in this recall

FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.

  • Classification
    Class II
  • Status
    Ongoing
  • Distribution
    US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, FL, GA, HI, IL, LA, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NY, OH, OK, OR, PA, PR, TN, TX, UT, VA, WA, WV.
Recall numberProduct, codes & lotsQuantity
Z-2271-2026Covidien Mon-a-Therm Esophageal Stethoscope with Temperature Sensor 400TM REF: 90042; UDI: 30884521820900/ Lot: 25D1267JZX 25E1322JZX, 25E1324JZX, 25H0920JZX,23,000 units
Z-2272-2026Covidien Mon-a-Therm General Purpose Temperature Probe REF: 90044; UDI: 30884521828388/ Lot: 25F0945JZX 25H0949JZX, 25I1065JZX, 25I1066JZX1775 units
Z-2273-2026Covidien Mon-a-Therm general purpose temperature probe size: 9 Fr REF: 90050; UDI: 10884521828391, 30884521828395/ Lot: 24D1130JZX 25A1086JZX 25E1332JZX 25I1054JZX 24D1133JZX 25A1087JZX 25F0946JZX 25I1055JZX 24E1015JZX 25A1088JZX 25F0947JZX 25I1056JZX 24E1017JZX 25D0379JZX 25F0948JZX 25I1057JZX 24E1018JZX 25D0380JZX 25F0949JZX 25I1058JZX 24L0848JZX 25D0381JZX 25F0950JZX 25I1059JZX 24L0850JZX 25D1271JZX 25F0953JZX 25I1061JZX 25A1069JZX 25D1272JZX 25F0954JZX 25K1129JZX 25A1070JZX 25D1273JZX 25G1163JZX 25K1130JZX 25A1072JZX 25E1263JZX 25H0935JZX 25K1131JZX 25A1075JZX 25E1264JZX 25H0936JZX 25L0542JZX 25A1076JZX 25E1265JZX 25H0938JZX 25L0545JZX 25A1077JZX 25E1326JZX 25H0939JZX 25L0899JZX 25A1082JZX 25E1329JZX 25H0940JZX 25L0901JZX 25A1084JZX 25E1331JZX 25H0942JZX 25L0903JZX 25A1085JZX128,900 units
Based on the official FDA remedy

What to do — step by step

  1. Check Device Details

    Review the unique device identifier (UDI) and lot numbers listed in the recall notice to confirm if your device is affected.

Where it went and when

Where it was distributed

Distributed nationwide; the notice names 31 states.

Alaska: named in the noticeAKMaine: nationwideMEVermont: nationwideVTNew Hampshire: nationwideNHWashington: named in the noticeWAIdaho: nationwideIDMontana: nationwideMTNorth Dakota: nationwideNDMinnesota: named in the noticeMNIllinois: named in the noticeILWisconsin: nationwideWIMichigan: named in the noticeMINew York: named in the noticeNYRhode Island: nationwideRIMassachusetts: named in the noticeMAOregon: named in the noticeORNevada: nationwideNVWyoming: nationwideWYSouth Dakota: nationwideSDIowa: nationwideIAIndiana: nationwideINOhio: named in the noticeOHPennsylvania: named in the noticePANew Jersey: named in the noticeNJConnecticut: nationwideCTCalifornia: named in the noticeCAUtah: named in the noticeUTColorado: named in the noticeCONebraska: named in the noticeNEMissouri: named in the noticeMOKentucky: nationwideKYWest Virginia: named in the noticeWVVirginia: named in the noticeVAMaryland: named in the noticeMDDelaware: nationwideDEArizona: named in the noticeAZNew Mexico: nationwideNMKansas: nationwideKSArkansas: named in the noticeARTennessee: named in the noticeTNNorth Carolina: named in the noticeNCSouth Carolina: nationwideSCDistrict of Columbia: nationwideDCOklahoma: named in the noticeOKLouisiana: named in the noticeLAMississippi: named in the noticeMSAlabama: named in the noticeALGeorgia: named in the noticeGAHawaii: named in the noticeHITexas: named in the noticeTXFlorida: named in the noticeFLPuerto Rico: named in the noticePR

FDA distribution: “US Nationwide distribution including in the states of AK, AL, AR, AZ, CA, CO, FL, GA, HI, IL, LA, MA, MD, MI, MN, MO, MS, NC, NE, NJ, NY, OH, OK, OR, PA, PR, TN, TX, UT, VA, WA, WV.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Named in the notice: Alabama, Alaska, Arizona, Arkansas, California, Colorado, Florida, Georgia, Hawaii, Illinois, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Nebraska, New Jersey, New York, North Carolina, Ohio, Oklahoma, Oregon, Pennsylvania, Puerto Rico, Tennessee, Texas, Utah, Virginia, Washington, West Virginia.

Recall timeline

FDA published this recall 48 days after the firm started it.

1. Firm started the recall: Apr 23, 202612. FDA classified it Class II: May 29, 202623. Published in FDA’s Enforcement Report: Jun 10, 202632026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest medical device recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #Z-2273-2026 (April 23, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-2273-2026 to see it in context.
  • Plain-language summary written by qwen3:4b on August 10, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA